NIBEC’s research institute, charged with leading its future vision, is engaged in R&D for medical supplies destined for overseas markets and developing market-oriented new products for the future.
The field of market-oriented product development is striving to make new products that maximize profits. This is done through developing new products stage-by-stage using peptides, tissue engineering products, and drug delivery systems.
The research institute is picking up pace in its R&D of new drugs based on its abundant R&D network, including clinics.
The bone generation business and medical supplies are scheduled for export following US FDA’s approval for the CGMP standard production facilities.
The research institute has built up a world-class R&D infrastructure through expanding research space, increasing investment and strengthening research networks. It will proceed to become a research hub, both in the domestic and world markets.
NIBEC continually invests a significant amount of its revenue on R&D, the growth engine for the future. It is doing all it can to become a global pharmaceutical company through providing an energetic environment where its associates can achieve their full potential.